Extended Lymphadenectomy and Vein Resection for Pancreatic Head Cancer: Outcomes and Implications for Therapy

Archives of Surgery

Volumn 138, Issue 12, 2003, Pages 1316-1322

  Capussotti, Lorenzo ^b   Massucco, Paolo ^a   Ribero, Dario ^b   Viganò, Luca ^b   Muratore, Andrea ^b   Calgaro, Marco ^b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PERIAMPULLARY ADENOCARCINOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL CANCER; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VEIN RESECTION; VEIN SURGERY;

ADENOCARCINOMA; FEMALE; HOSPITAL MORTALITY; HUMANS; LYMPH NODE EXCISION; MALE; MESENTERIC VEINS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0344629903     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.12.1316     Document Type: Article

References (33)

1. Faivre J, Forman D, Esteve J, Obradovic M, Sant M, EUROCARE Working Group. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer. 1998;34:2184-2190.
2. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447-458.
3. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993;217:430-435.
4. Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg. 1988;208:215-220.
5. Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer. 1989;64:1132-1137.
6. Nagakawa T, Konishi I, Ueno K, et al. Surgical treatment of pancreatic cancer: the Japanese experience. Int J Pancreatol. 1991;9:135-143.
7. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Lymphadenectomy Study Group. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Ann Surg. 1998;228:508-517.
8. Henne-Bruns D, Vogel I, Luttges J, Kloppel G, Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head. World J Surg. 2000;24:595-601.
9. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with of without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampuilary adenocarcinoma, part 2. Ann Surg. 2002;236:355-368.
10. Fuhrman GM, Leach SD, Staley CA, et al. Pancreatic Tumor Study Group. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg. 1996;223:154-162.
11. Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. Ann Surg. 1996;224:342-347.
12. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg. 1994;81:1190-1193.
13. Allema JH, Reinders ME, van Gulik TM, et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg. 1994;81:1642-1646.
14. Hamilton SR, Aaitonen LA. Pathology and Genetics of Tumours of the Digestive System. Washington, DC: IARC Press; 2000.
15. International Union Against Cancer (UICC). TNM: Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
16. Japan Pancreas Society. Classification of Pancreatic Carcinoma. Tokyo, Japan: Kanehara & Co Ltd; 1996.
17. Fortner JG. Regional resection of cancer of the pancreas: a new surgical approach. Surgery. 1973;73:307-320.
18. Hirata K, Sato T, Mukaiya M, et al. Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg. 1997;132:771-776.
19. Gall FP, Kessler H, Hermanek P. Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol. 1991;17:173-181.
20. Massucco P, Calgaro M, Bertolino F, Bima C, Galatola G, Capussotti L. Outcome of surgical treatment for chronic calcifying pancreatitis. Pancreas. 2001;22:378-382.
21. van Heerden JA, ReMine WH, Weiland LH, McIlrath DC, Ilstrup DM. Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo Clinic experience. Am J Surg. 1981;142:308-311.
22. Andren-Sandberg A, Ihse I. Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg. 1983;198:605-610.
23. Allema JH, Reinders ME, van Gulik TM, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995;75:2069-2076.
24. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 1997;225:621-633.
25. Millikan KW, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg. 1999;65:618-623.
26. Park SJ, Kim SW, Jang JY, Lee KU, Park YH. Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy? World J Surg. 2002;26:487-492.
27. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg. 1994;129:1075-1080.
28. Kokubo M, Nishimura Y, Shibamoto Y, et al. Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2000;48:1081-1087.
29. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120-124.
30. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68-72.
31. Roder JD, Stein HJ, Siewert JR Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg. 1996;171:170-174.
32. Kremer B, Vogel I, Luttges J, Kioppel G, Henne-Bruns D. Surgical possibilities for pancreatic cancer: extended resection. Ann Oncol. 1999;10(suppl 4):252-256.
33. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery. 1995;117:50-55.